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Carbonic anhydrase II (CA II) generates the H ÷ required for oste elast-mediated bone resorption n humans. We have 
developed the human promyelocytic cell line HL-60 as a model system with which to study the oste clast-specific expres- 
sion of the CA II gene. Treatment ofthe cell line with 1,25-dihydroxyvitamin D 3 resulted in a dramatic de novo induction 
of CA II at both the protein and mRNA levels. CA II mRNA was also induced to a lesser extent by 12-O-tetradecanoyl 
phorbol 13-acetate. Treatment with dimethyl sulfoxide did not increase CA II mRNA. These findings indicate that the 
HL-60 cell line will be a useful model system to study the osteoclast-speeific xpression fthe CA II gene. 
Carbonic anhydrase II; Osteoclast; Dihydroxyvitamin D3,1,25-; (HL-60 cell) 
1. INTRODUCTION 
Carbonic anhydrase (CA, EC 4.2.1.1) catalyzes 
the interconversion of carbon dioxide and water to 
bicarbonate and protons. A considerable amount 
of information is known about he molecular 
structures, genetics, evolution, and physiological 
roles of the different CA isozymes [1]. In mam- 
mals, the CA isozymes are coded by at least seven 
genes, designated CA I -CA  VII, which in general 
have different tissue specificities and probably 
varying physiological roles [2]. In humans, an in- 
herited deficiency of CA II (CA II deficiency syn- 
drome) is characterized by osteopetrosis, renal 
tubular acidosis, and cerebral calcification [3] and 
in mice by renal tubular acidosis [4] and vascular 
calcifications [5]. The osteopetrosis in CA II defi- 
ciency syndrome is an osteoclast-specific defect as 
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shown by two lines of evidence. CA II in bone is 
found only in osteoclasts in a variety of species 
[6-10], and variation in the activity of CA II 
caused by hormonal treatment (e.g. parathyroid 
hormone) in bone culture influences the degree of 
bone resorption [11]. 
Because the study of CA II gene regulation at 
the molecular level is hampered by the difficulty of 
obtaining a sufficient number of purified 
osteoclasts, a model cell culture system is needed. 
Since there is a close developmental relationship 
between osteoclasts and macrophages and 
monocytes [12], it might be possible to study CA 
II gene regulation in a cell line derived from the lat- 
ter cell types. The HL-60 cell line, derived from a 
patient with promyelocytic leukemia, can be in- 
duced to undergo monocytic differentiation by a 
variety of compounds [13] including 1,25-dihy- 
droxyvitamin D3 [I,25-(OH)2D3], a hormone 
known to affect strongly bone resorption [14]. 
Trace levels of CA II have been found in unin- 
duced HL-60 cells [15]. We reasoned that this cell 
line might provide a potential model for the regula- 
tion of the CA II gene in the osteoclast, and that 
CA II might be induced to higher levels by expos- 
ing the cells to 1,25-(OH)2D3. It is shown here that 
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such an induction does occur for both CA II 
mRNA and protein. 
2. MATERIALS AND METHODS 
2.1. Cell culture and treatments 
HL-60 cells were grown in RPMI-1640 medium with 10% 
fetal calf serum. Cells were induced with 1,25-(OH)2D3, 12-0- 
tetradecanoyl phorbol 13-acetate (TPA), or dimethyl sulfoxide 
(DMSO) for varying lengths of time as described in the figure 
legends. The concentrations were 10 nM 1,25-(OH)2D3, 10 nM 
TPA and 1.25°70 DMSO. 
2.2. Northern blots 
RNA was isolated by a guanidine-HC1 procedure [16]. RNAs 
(10/~g per lane, except as noted) were run in formaldehyde g ls 
and transferred to nylon membranes by capillary blotting [17]. 
The amount of RNA loaded was confirmed by ethidium 
bromide staining. Blots were probed with randomly primed [18] 
human CA II cDNA [19], washed and autoradiographed. Some 
blots were also probed with human CA I [20], CA III [21], and 
CA VII DNAs [22]. 
2.3. Western blots 
Cell lysates were prepared by freeze-thawing cells in 
phosphate-buffered saline and pelleting the debris. 50/~g pro- 
tein per lane were run on SDS gels, transferred toa nylon mem- 
brane [23], and probed with rabbit anti-human CA II followed 
by goat anti-rabbit IgG conjugated to alkaline phosphatase. 
Blots were developed with nitroblue tetrazolium and 
bromochloroindoyl phosphate [24]. 
Fig.1. Northern blot showing effect of 1,25-(OH)zD3, TPA, 
and DMSO on CA II induction in HL-60 cells. All lanes 
contained 10/zg total RNA except lane 3 which had 25/zg total 
RNA. HL-60 cells were treated for 48 h with each inducing 
agent at he concentrations given in section 2. Lanes: (1) 
uninduced, (2,3) induced with 1,25-(OH)2D3, (4) induced with 
DMSO, (5) induced with TPA. The blot was probed with the 
cloned human CA II cDNA [14]. 
2.4. Cellulose acetate electrophoresis 
Human CA I and CA II were purified from hemolysates by
affinity chromatography as described [25]. Cellulose acetate 
electrophoresis, using a buffer composed of 0.44 M Tris, 
50 mM boric acid, and 15 mM EDTA at pH 9.1, was perform- 
ed at 300 V for 3 h [26]. Carbonic anhydrase activity was 
detected by a CO2-driven indicator (bromothymol b ue) color 
change as described in [27]. 
3. RESULTS 
3.1. CA H mRNA is induced by 
1,25-dihydroxyvitamin 193
The treatment of HL-60 cells with 1,25-(OH)2Da 
or TPA, another eagent commonly used to induce 
HL-60 cells along a monocytic differentiation 
pathway, results in the induction of CA II mRNA 
after 48 h incubation (fig.l). However, treatment 
of the cells with DMSO, which causes HL-60 cells 
to undergo granulocytic differentiation [13], does 
not result in induction of CA II mRNA. Den- 
sitometric scans of the lanes give estimates of a 
5-fold increase of TPA-induced CA II message and 
a 20-fold increase with 1,25-(OH)2Da after 48 h. 
The blot was also probed with human CA I, CA 
II I ,  and CA VII DNAs. No signal was obtained 
with any of these probes (not shown). Probes for 
other CA isozymes are not yet available. 
3.2. Rate of CA H mRNA induction 
The time course of the change in CA II mRNA 
levels in HL-60 cells was determined after treat- 
ment with TPA, 1,25-(OH)2D3, and DMSO. The 
CA II mRNA levels in TPA-treated cells appear to 
peak at 48 h and decrease slightly at 72 and 96 h 
(fig.2). No increase in CA II mRNA was detected 
after 3 h exposure to 1,25-(OH)2D3; however, an 
increase was detected at 24 h, which continued to 
rise up to 96 h (fig.2). CA II mRNA levels were not 
observed to change from control levels throughout 
96 h of treatment with DMSO (not shown). 
3.3. CA H protein is induced by 
1,25-dihydroxyvitamin Ds 
Several Western blots of treated HL-60 cell 
lysates were carried out, and a representative blot 
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Fig.2. TPA and 1,25-(OH)2D3 time courses of CA I1 mRNA 
induction in HL-60 cells shown by Northern blot analysis. Cells 
were induced under standard conditions as described in the text 
and harvested atvarious times. Lanes: (1,6) control ceils, (2-5) 
treated with TPA, (7-12) treated with 1,25-(OH)2D~. Times of 
treatment: (2,9) 24 h, (3,10) 48 h, (4,11) 72 h, (5,12) 96 h, (7) 
1 h, (8) 3 h. 
is shown in fig.3. A trace amount  of  CA  II protein 
can be seen in control  cells, and an equivalent 
amount  can be observed in 72 and 96 h DMSO-  
treated lysates. In contrast,  an approx.  10-fold in- 
crease in CA II  protein can be seen in 72 and 96 h 
1,25-(OH)2D3-induced lysates. No increase in CA 
II  prote in could be detected at 48 h of  t reatment 
with 1,25-(OH)2D3 (not shown). When compared 
to known amounts of  puri f ied human CA II ,  it was 
est imated that 50 ng CA II  was present at 96 h of  
induct ion in 50/zg soluble protein.  
Fig.4. Cellulose acetate lectrophoresis of cell lysates stained 
for carbonic anhydrase activity at various times of treatment 
with 1,25-(OH)2D3. Lanes: (1) purified human CA I control; 
(2) purified human CA II control. Remaining lanes of induced 
lysate: (3) 0 h, (4) 24 h, (5) 48 h, (6) 72 h, (7) 96 h. 
3.4. CA H appears to be the only CA in HL-60 
cells 
To conf i rm the identity of  the isozyme as CA II ,  
lysates were run on a cellulose acetate membrane 
and stained for carbonic anhydrase activity (fig.4). 
An  increase in activity can be detected at 72 and 
96 h in a band that co-migrates with CA II ,  but not 
with CA I. No increase in CA II activity can be 
1 2 ...... 3 . . . . . .  4 5 
Fig.3. Western blot of cell lysates from DMSO- and 
1,25-(OH)2Drtreated ceils. 50/zg protein were loaded per lane. 
(1) Control cells; (2) DMSO, 72 h; (3) DMSO, 96 h; (4) 
1,25-(OH)2D3, 72 h; (5) 1,25-(OH)2D3, 96 h. 
observed at 48 h (not shown). CA  I I I  migrates to 
another  posit ion in this system, but because of  its 
substant ial ly lower carbonic anhydrase activity 
[28], it was not included in this experiment.  
4. D ISCUSSION 
We have developed a model  cell culture system 
which can be used to study the osteoclast-specif ic 
regulat ion of  the human CA II gene. HL-60 cells 
respond to a variety of  hormones that also effect 
bone metabol ism [12,13]. The effect of  these hor-  
mones on the regulat ion of  the CA II  gene can now 
be studied at the molecular  level. A l though HL-60 
cells express CA II, this is not so in cultured rat 
per ipheral  monocytes,  and most types of  macro-  
phages [8]. Consider ing the close developmental  
relat ionships between osteoclasts and monocytes 
and macrophages,  as well as the sometimes aber- 
rant nature of  genetic programs of  neoplastic ells, 
these results are not surprising. Both osteoclasts 
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and HL-60 cells appear  to express only the CA II 
isozyme. 
The human and mouse CA II  genes have been 
cloned and their promoter  egions sequenced [29]. 
The promoter  lies within a GC-r ich island, and the 
minimal  elements required for high-level expres- 
sion in human HeLa  cells and mouse L cells have 
been identif ied [30]. However,  pre l iminary ex- 
per iments in which the minimal  promoter  has been 
transfected into HL-60 ceils has shown that,  
a l though the TPA-respons ive lement is present, 
the 1,25-(OH)2Drresponsive element lies outside 
of  this region (L .H.S.  and P . J .V . ,  unpubl ished).  
Since little is known about  how 1,25-(OH)2Da 
affects the expression o f  genes at he molecular  
level, this model  system should provide some 
valuable insights into the regulatory effects of  this 
hormone.  Once the regulat ion of  the CA II  gene is 
understood in HL-60 cells, critical experiments can 
be designed to examine its regulat ion in l imited 
amounts  of  puri f ied osteoclasts. In addit ion,  the 
results obtained may be useful for developing a 
successful gene replacement therapy of  the recently 
descr ibed CA I I -def ic ient mouse model  [4]. 
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